Press Releases Filter Filter Results Year 2024 (4) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) November 19, 2019 Abiomed Medical Office Completes Review of Observational Analysis of Impella Presented at AHA November 14, 2019 Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock October 31, 2019 First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump October 31, 2019 Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 29.4% Operating Margin October 25, 2019 FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival October 10, 2019 Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification October 7, 2019 Abiomed Announces 1,000th Patient Treated with Impella in Japan September 27, 2019 Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock; Escalation Protocols Initiated September 26, 2019 PROTECT III Presented at TCT 2019 – Clinical Data Demonstrates Protected PCI with Impella is Associated with Improved Outcomes September 25, 2019 Abiomed Receives FDA PMA Approval for Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump September 23, 2019 Highest Court in Germany Affirms Strength of Abiomed’s Patents September 17, 2019 Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019 September 3, 2019 Abiomed to Present at the Morgan Stanley Global Healthcare Conference August 31, 2019 Impella® SmartAssist Platform Launches at ESC, Designed to Further Improve Patient Outcomes August 1, 2019 Abiomed Announces Q1 FY 2020 Revenue of $208 Million and 29.2% Operating Margin … 6 7 8 9 …
